As no variants tested in this study remained independently predictive after adjusting for multiple testing and combined within a genetic risk model showed no improvement on the predictive capability of serum PSA testing, highlights the need for independent prostate cancer genetic marker identification within the context of Africa. The gene discussed is KLK3; the disease is prostate carcinoma.